The article reports on the announcement of Isis Pharmaceuticals Inc. that it has added a new drug to its development pipeline, ISIS-FGFR4Rx, which is designed to treat obesity by increasing metabolism, particularly by increasing lipid and fat burning in Carlsbad, California....